ONCASPAR (Baxalta US Inc.)
Welcome to the PulseAid listing for the ONCASPAR drug offered from Baxalta US Inc.. This Asparaginase [Chemical/Ingredient],Asparagine-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Baxalta US Inc. |
| NON-PROPRIETARY NAME: | Pegaspargase |
| SUBSTANCE NAME: | PEGASPARGASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Asparaginase [Chemical/Ingredient],Asparagine-specific Enzyme [EPC] |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1994-02-01 |
| END MARKETING DATE: | 0000-00-00 |
ONCASPAR HUMAN PRESCRIPTION DRUG Details:
| Item Description | ONCASPAR from Baxalta US Inc. |
| LABELER NAME: | Baxalta US Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 750([iU]/mL) |
| START MARKETING DATE: | 1994-02-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0944-3810_36073876-490a-4df4-a3b3-a9df985797d8 |
| PRODUCT NDC: | 0944-3810 |
| APPLICATION NUMBER: | BLA103411 |
Other PEGASPARGASE Pharmaceutical Manufacturers / Labelers:
